ResMed Inc. (RMD.AX)
ASX - ASX Delayed price. Currency in AUD
Add to watchlist
At close: 04:10PM AEST
| Previous close | 31.40 |
| Open | 31.04 |
| Bid | 32.00 x 51100 |
| Ask | 31.35 x 25600 |
| Day's range | 31.02 - 31.24 |
| 52-week range | 21.14 - 34.27 |
| Volume | |
| Avg. volume | 2,294,813 |
| Market cap | 46.134B |
| Beta (5Y monthly) | 0.64 |
| PE ratio (TTM) | 32.11 |
| EPS (TTM) | 0.97 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | 0.29 (0.94%) |
| Ex-dividend date | 08 May 2024 |
| 1y target est | 34.94 |
ZacksOmnicell (OMCL) Gains From New Offerings Amid Cost Woes
With the EnlivenHealth platform, Omnicell (OMCL) is gaining momentum with cross-selling and up-selling communication solutions to existing customers.
ZacksQIAGEN (QGEN) Advances Precision Medicine With New QIAseq Kit
QIAGEN (QGEN) launches the new QIAseq Multimodal DNA/RNA Lib Kit, facilitating multiomic studies and advancing precision medicine.
Zacks3 Reasons Growth Investors Will Love ResMed (RMD)
ResMed (RMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.
© 2024 Yahoo. All rights reserved.